Alternatives to Zappy Health

The oversight-forward compounder: labs and a live provider visit bundled into every plan, with a gentle microdosing lane — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

The whole price table before you hand over a detail: $175/mo semaglutide with no commitment, flat at every dose. The advertised $146 is $875 prepaid for six months — and nothing renews on its own.

One flat monthly charge with everything genuinely inside it — $199 and $269, no membership or consult fee — plus a published “prescribed today, delivered in two days.”

AurenRx names both the practice that prescribes and the pharmacy that compounds, with addresses — Wasef Health, PC c/o Michael Wasef MD in Pinellas Park, Florida, and VialsRX in Houston, Texas — and the prescriber's details match the federal NPI registry exactly. It charges the same for either molecule, which is genuinely unusual: $259 a month on a recurring plan or $299 with no commitment, for semaglutide or tirzepatide alike, plus a low-and-slow microdose track at $229/$250. Everything is included in that price, the online visit is free, and the LegitScript badge it displays is real. The problem is its own front page. AurenRx advertises its GLP-1 and Microdose programs at 'from $129/mo' on the homepage, while the cheapest thing you can actually buy on the product page is $229 — nothing costs $129. That is not a promotion that expired or a plan you have to hunt for; it is roughly half the real price, sitting on the page most readers see first.

It shows both prices at once and says which is which: $149/mo with no commitment, $79 on a twelve-month plan. Brand-name is listed, but all three pages say coming soon.

The Edit is one of the very few providers on this page that names both the medical practice writing your prescription and the pharmacy compounding it — Arora Health & Aesthetics, LLC and The Pharmacy Hub — rather than gesturing at 'licensed US providers'. Compounded semaglutide is $209 a month and tirzepatide $309, the same price at every dose, with the prescription, all injection supplies, the clinician visit and temperature-controlled two-day shipping inside that one number and no membership fee on top. First orders are $100 off, and three- and six-month plans bring the per-month equivalent down to $192 and $178 for semaglutide. It covers all 50 states and, unusually for this market, runs a complete Spanish-language version of the site rather than a machine-translated shim. The limits are real but narrow: it is compounded-only, so there is no FDA-approved Wegovy or Zepbound here, and there is no postpartum, breastfeeding or PCOS guidance anywhere on the site.

The number on the page is a prepay. Read live on 2026-08-26, GOAL.MD's semaglutide page leads with $99 a month and its tirzepatide page with $159 — and both are 12-month prepaid equivalents, $1,188 and $1,908 handed over up front. Month to month, the same two medications are $179 and $249. The site does say so, in the same sentence, but second. Everything around that pricing is unusually clean for this roster: a named physician with a searchable NPI rather than an anonymous clinical network, "No Auto-Billing. Ever." with a stated check-in before every renewal, a 3-minute online medical visit with no video call mentioned anywhere in the copy, and a published timeline — physician decision in about 24 hours, free shipping in 2–3 days. Two corrections to make if you are comparing: it serves 48 states rather than the whole country, and its brand-name lane is a forwarding service where you pay GOAL.MD $95 a month for supervision and the manufacturer program directly for the drug.